Physician profile
Charles Williams
NPI 1205929262
$3,116.79
in general payments reported to CMS, 2019-2025
14 companies · $20.21 in 2025
The $20.21 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $1,381 · 2021: $780 · 2022: $41.77 · 2023: $146 · 2025: $20.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $1,176.19 | 2019-2022 | |
| Edwards Lifesciences Corporation | $560.14 | 2020 | |
| Abbott Laboratories | $337.64 | 2019-2025 | Anthem, Navitor |
| Abiomed | $261.42 | 2019-2021 | |
| Livanova USA, INC. | $145.55 | 2021 | |
| Janssen Pharmaceuticals, INC | $129.82 | 2019 | |
| Medtronic Vascular, INC. | $117.91 | 2019 | |
| Inari Medical, INC. | $100.01 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $95.94 | 2019 | |
| Atricure, INC. | $68.94 | 2020-2021 | |
| Fisher Scientific Company L.L.C. | $50.51 | 2019 | |
| Silk Road Medical, INC. | $32.57 | 2021 | |
| Medtronic, INC. | $21.19 | 2023 | Endurant Iis |
| Getinge USA Sales, LLC | $18.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.